← Leaderboards
Joren C Madsen
Massachusetts General Hospital
$70,026,219
Attributed
$81,085,442
Total exposure
33
Grants
31
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $18.4M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$157,531,422 · 40
By mechanism
P01$74,946,169 · 18
U01$43,967,465 · 5
U19$29,208,600 · 11
R01$6,951,025 · 4
T32$2,165,138 · 1
R34$293,025 · 1
Top collaborators
- Ramsey Hachem5 shared
- Daniel Kreisel5 shared
- Zahi A. Fayad3 shared
- Tatsuo Kawai2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- David Kc Cooper$22,744,194
- Simon C Robson$16,000,011
- J. Scott Arn$10,295,294
- James F Markmann$21,074,268
- Matthias Nahrendorf$28,669,447
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationHeart AllograftNonhuman PrimateProgramsHeart TransplantationTransplant RecipientsKidneyRegulatory T-LymphocyteNovel StrategiesOrganKidney AllograftAllograft ToleranceChronicOrgan TransplantationProtocols DocumentationHeartDesignAllograftingImmuneFundingResistancePreventT-LymphocyteImmunosuppression
Grant awards (166)
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,310,755
U01 · FY2025 · AI · contact PI
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs$3,299,788
U19 · FY2025 · AI · contact PI
Targeting trained immunity in transplantation$3,010,650
P01 · FY2025 · AI
New Approaches to Inducing Cardiac Allograft Tolerance$2,423,933
P01 · FY2025 · HL · contact PI
Project 2: Translating Cardiac Xenotransplantation$876,896
U19 · FY2025 · AI · contact PI
Infrastructure and Opportunities Fund Management Core$865,000
U19 · FY2025 · AI · contact PI
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs$865,000
U19 · FY2025 · AI · contact PI
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates$816,856
P01 · FY2025 · AI · contact PI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism$745,309
P01 · FY2025 · HL · contact PI
Infrastructure and Opportunities Fund Management Core$659,958
U19 · FY2025 · AI · contact PI
Administrative Core$659,958
U19 · FY2025 · AI · contact PI
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs$659,957
U19 · FY2025 · AI · contact PI
Administrative Core$89,928
P01 · FY2025 · HL · contact PI
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs$3,401,842
U19 · FY2024 · AI · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,256,574
U01 · FY2024 · AI · contact PI
Targeting trained immunity in transplantation$3,018,892
P01 · FY2024 · AI
New Approaches to Inducing Cardiac Allograft Tolerance$2,377,801
P01 · FY2024 · HL · contact PI
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs$1,319,385
U19 · FY2024 · AI · contact PI
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates$818,648
P01 · FY2024 · AI · contact PI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism$737,997
P01 · FY2024 · HL · contact PI
Infrastructure and Opportunities Fund Management Core$400,000
U19 · FY2024 · AI · contact PI
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs$400,000
U19 · FY2024 · AI · contact PI
Infrastructure and Opportunities Fund Management Core$399,344
U19 · FY2024 · AI · contact PI
Training in Transplantation Biology$344,653
T32 · FY2024 · AI · contact PI
Administrative Core$118,998
U19 · FY2024 · AI · contact PI
Administrative Core$80,223
P01 · FY2024 · HL · contact PI
Novel Approaches to Inducing Lung Allograft Tolerance in NHPs$3,485,857
U19 · FY2023 · AI · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,130,730
U01 · FY2023 · AI · contact PI
Targeting trained immunity in transplantation$3,012,041
P01 · FY2023 · AI
New Approaches to Inducing Cardiac Allograft Tolerance$2,428,802
P01 · FY2023 · HL · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$2,426,322
U01 · FY2023 · AI · contact PI
Project 1: Next Generation Mixed Chimerism Strategies to Induce Lung Allograft Tolerance in NHPs$1,352,884
U19 · FY2023 · AI · contact PI
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates$919,879
P01 · FY2023 · AI · contact PI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism$750,178
P01 · FY2023 · HL · contact PI
Infrastructure and Opportunities Fund Management Core$399,343
U19 · FY2023 · AI · contact PI
Training in Transplantation Biology$332,452
T32 · FY2023 · AI · contact PI
Administrative Core$119,271
U19 · FY2023 · AI · contact PI
Administrative Core$89,928
P01 · FY2023 · HL · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$3,063,266
U01 · FY2022 · AI · contact PI
New Approaches to Inducing Cardiac Allograft Tolerance$2,428,802
P01 · FY2022 · HL · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$1,996,091
U01 · FY2022 · AI · contact PI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism$750,178
P01 · FY2022 · HL · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$608,912
U01 · FY2022 · AI · contact PI
Training in Transplantation Biology$321,296
T32 · FY2022 · AI · contact PI
Administrative Core$89,928
P01 · FY2022 · HL · contact PI
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab$2,710,272
U01 · FY2021 · AI · contact PI
New Approaches to Inducing Cardiac Allograft Tolerance$2,462,802
P01 · FY2021 · HL · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$858,721
U01 · FY2021 · AI · contact PI
Achieving Clinically Relevant Tolerance in NHP Heart Allograft Recipients$808,124
R01 · FY2021 · AI · contact PI
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism$767,178
P01 · FY2021 · HL · contact PI
Training in Transplantation Biology$306,384
T32 · FY2021 · AI · contact PI
Administrative Core$89,928
P01 · FY2021 · HL · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$44,565
U01 · FY2021 · AI · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$1
U01 · FY2021 · AI · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$2,457,204
U01 · FY2020 · AI · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$2,058,639
P01 · FY2020 · AI · contact PI
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation$901,353
P01 · FY2020 · AI · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$858,721
U01 · FY2020 · AI · contact PI
Defining The Immune Response to SARS-CoV-2 in Aging$361,494
U01 · FY2020 · AI · contact PI
Training in Transplantation Biology$309,611
T32 · FY2020 · AI · contact PI
Administrative Core$128,251
P01 · FY2020 · AI · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$2,569,903
U01 · FY2019 · AI · contact PI
New Approaches to Cardiothoracic Tolerance Induction$2,170,762
P01 · FY2019 · HL · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$2,058,639
P01 · FY2019 · AI · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$1,020,315
U01 · FY2019 · AI · contact PI
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation$904,050
P01 · FY2019 · AI · contact PI
Project #1: Optimizing Mixed Chimerism for Heart Transplantation in Non-Human Pri$623,875
P01 · FY2019 · HL · contact PI
Administrative Core$133,492
P01 · FY2019 · HL · contact PI
Administrative Core$128,919
P01 · FY2019 · AI · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$3,029,663
U01 · FY2018 · AI · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$2,223,329
P01 · FY2018 · AI · contact PI
New Approaches to Cardiothoracic Tolerance Induction$2,170,762
P01 · FY2018 · HL · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$1,391,561
U01 · FY2018 · AI · contact PI
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation$903,306
P01 · FY2018 · AI · contact PI
Project #1: Optimizing Mixed Chimerism for Heart Transplantation in Non-Human Pri$623,875
P01 · FY2018 · HL · contact PI
Training in Transplantation Biology$278,652
T32 · FY2018 · AI · contact PI
Administrative Core$133,493
P01 · FY2018 · HL · contact PI
Administrative Core$128,768
P01 · FY2018 · AI · contact PI
New Approaches to Cardiothoracic Tolerance Induction$2,170,762
P01 · FY2017 · HL · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$2,058,639
P01 · FY2017 · AI · contact PI
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation$901,355
P01 · FY2017 · AI · contact PI
Mixed chimerism induced tolerance in heart recipients requires donor kidney cotransplantation$858,721
U01 · FY2017 · AI · contact PI
Project #1: Optimizing Mixed Chimerism for Heart Transplantation in Non-Human Pri$623,876
P01 · FY2017 · HL · contact PI
Training in Transplantation Biology$272,090
T32 · FY2017 · AI · contact PI
Administrative Core$164,690
P01 · FY2017 · AI · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$164,690
P01 · FY2017 · AI · contact PI
Administrative Core$133,491
P01 · FY2017 · HL · contact PI
Administrative Core$128,250
P01 · FY2017 · AI · contact PI
New Approaches to Cardiothoracic Tolerance Induction$2,170,762
P01 · FY2016 · HL · contact PI
Mechanisms of Kidney-Induced Cardiac Allograft Tolerance$2,076,389
P01 · FY2016 · AI · contact PI
Project 1: Induction of Tolerance to Heart Allograft in Nonhuman Primates by Donor Kidney Co-Transplantation$815,237
P01 · FY2016 · AI · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$665,666
U01 · FY2016 · AI · contact PI
Project #1: Optimizing Mixed Chimerism for Heart Transplantation in Non-Human Pri$627,866
P01 · FY2016 · HL · contact PI
Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab$293,025
R34 · FY2016 · AI · contact PI
Administrative Core$130,014
P01 · FY2016 · HL · contact PI
Administrative Core$107,230
P01 · FY2016 · AI · contact PI
New Approaches to Cardiothoracic Tolerance Induction$2,207,762
P01 · FY2015 · HL · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$961,500
U01 · FY2015 · AI · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$961,500
U01 · FY2015 · AI · contact PI
Project #1: Optimizing Mixed Chimerism for Heart Transplantation in Non-Human Pri$623,876
P01 · FY2015 · HL · contact PI
Administrative Core$133,491
P01 · FY2015 · HL · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$856,882
U01 · FY2014 · AI · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$767,124
U01 · FY2014 · AI · contact PI
New Approaches To Cardiothoracic Tolerance Induction$1,929,037
P01 · FY2013 · HL · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$845,208
U01 · FY2013 · AI · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$616,346
U01 · FY2013 · AI · contact PI
Optimizing Mixed chimerism for Heart Transplantation in Nonhuman Primates$491,168
P01 · FY2013 · HL · contact PI
Administrative and Biostatistics$93,270
P01 · FY2013 · HL · contact PI
New Approaches To Cardiothoracic Tolerance Induction$2,027,914
P01 · FY2012 · HL · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$856,882
U01 · FY2012 · AI · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$614,587
U01 · FY2012 · AI · contact PI
Optimizing Mixed chimerism for Heart Transplantation in Nonhuman Primates$515,860
P01 · FY2012 · HL · contact PI
Administrative and Biostatistics$97,960
P01 · FY2012 · HL · contact PI
New Approaches To Cardiothoracic Tolerance Induction$2,034,794
P01 · FY2011 · HL · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$857,225
U01 · FY2011 · AI · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$614,832
U01 · FY2011 · AI · contact PI
Optimizing Mixed chimerism for Heart Transplantation in Nonhuman Primates$518,346
P01 · FY2011 · HL · contact PI
Administrative and Biostatistics$99,851
P01 · FY2011 · HL · contact PI
New Approaches To Cardiothoracic Tolerance Induction$2,038,141
P01 · FY2010 · HL · contact PI
Tolerance Strategies in Non-Human Primate Cardiac Allograft Recipients$812,889
U01 · FY2010 · AI · contact PI
Optimizing Mixed-Chimerism for Heart Transplantation in Non-Human Primates$752,796
R01 · FY2010 · HL · contact PI
Achieving Tolerance to Cardiac Allografts using Vascularized Donor Thymus$583,033
U01 · FY2010 · AI · contact PI
Optimizing Mixed chimerism for Heart Transplantation in Nonhuman Primates$519,909
P01 · FY2010 · HL · contact PI
Administrative and Biostatistics$100,412
P01 · FY2010 · HL · contact PI
New Approaches To Cardiothoracic Tolerance Induction$2,068,051
P01 · FY2009 · HL · contact PI
THORACIC ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES$1,292,203
U19 · FY2009 · AI · contact PI
Optimizing Mixed-Chimerism for Heart Transplantation in Non-Human Primates$736,855
R01 · FY2009 · HL · contact PI
Novel Tolerance Strategies in Cardiac Allograft Recipients$732,186
U19 · FY2009 · AI · contact PI
Optimizing Mixed chimerism for Heart Transplantation in Nonhuman Primates$521,286
P01 · FY2009 · HL · contact PI
Administrative and Biostatistics$101,117
P01 · FY2009 · HL · contact PI
Core--Administration and Statistics$43,759
U19 · FY2009 · AI · contact PI
THORACIC ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES$1,261,151
U19 · FY2008 · AI · contact PI
Novel Tolerance Strategies in Cardiac Allograft Recipients$712,971
U19 · FY2008 · AI · contact PI
Core--Administration and Statistics$42,970
U19 · FY2008 · AI · contact PI
THORACIC ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES$1,254,842
U19 · FY2007 · AI · contact PI
Novel Tolerance Strategies in Cardiac Allograft Recipients$567,695
U19 · FY2007 · AI · contact PI
Tolerance to heart transplants in Miniature Swine$521,103
P01 · FY2007 · HL · contact PI
CARDIAC ALLOGRAFT VASCULOPATHY IN LARGE ANIMALS$498,012
R01 · FY2007 · HL · contact PI
Core--Administration and Statistics$106,783
U19 · FY2007 · AI · contact PI
THORACIC ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES$1,261,585
U19 · FY2006 · AI · contact PI
Novel Tolerance Strategies in Cardiac Allograft Recipients$582,612
U19 · FY2006 · AI · contact PI
CARDIAC ALLOGRAFT VASCULOPATHY IN LARGE ANIMALS$420,412
R01 · FY2006 · HL · contact PI
Tolerance to heart transplants in Miniature Swine$418,796
P01 · FY2006 · HL · contact PI
Cardiac Allograft Vasculopathy in Immunodeficient Mice$380,103
R01 · FY2006 · HL · contact PI
Core--Administration and Statistics$110,440
U19 · FY2006 · AI · contact PI
CARDIAC ALLOGRAFT VASCULOPATHY IN LARGE ANIMALS$36,972
R01 · FY2006 · HL · contact PI
THORACIC ALLOGRAFT TOLERANCE IN NON-HUMAN PRIMATES$1,274,665
U19 · FY2005 · AI
Novel Tolerance Strategies in Cardiac Allograft Recipients$570,140
U19 · FY2005 · AI
Tolerance to heart transplants in Miniature Swine$519,795
P01 · FY2005 · HL
CARDIAC ALLOGRAFT VASCULOPATHY IN LARGE ANIMALS$418,625
R01 · FY2005 · HL
Cardiac Allograft Vasculopathy in Immunodeficient Mice$389,250
R01 · FY2005 · HL
Core--Administration and Statistics$111,117
U19 · FY2005 · AI
Tolerance to heart transplants in Miniature Swine$507,825
P01 · FY2004 · HL
CARDIAC ALLOGRAFT VASCULOPATHY IN LARGE ANIMALS$404,107
R01 · FY2004 · HL
Cardiac Allograft Vasculopathy in Immunodeficient Mice$389,250
R01 · FY2004 · HL
Tolerance to heart transplants in Miniature Swine$493,034
P01 · FY2003 · HL
Cardiac Allograft Vasculopathy in Immunodeficient Mice$389,250
R01 · FY2003 · HL
CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE$393,360
R01 · FY2002 · HL
CORE--ANIMAL AND ANTIBODY FACILITY$296,242
P01 · FY2002 · AI
Immunorecognition in chronic allograft rejection$0
P01 · FY2002 · AI
CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE$468,212
R01 · FY2001 · HL
CORE--ANIMAL AND ANTIBODY FACILITY$296,242
P01 · FY2001 · AI
Immunorecognition in chronic allograft rejection$0
P01 · FY2001 · AI
CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE$380,197
R01 · FY2000 · HL
CORE--ANIMAL AND ANTIBODY FACILITY$296,242
P01 · FY2000 · AI
CARDIAC ALLOGRAFT VASCULOPATHY IN MINIATURE SWINE$85,500
R01 · FY2000 · HL